GHSI Bullish Divergence Signal Monthly ChartGHSI is forming lower lows on the monthly chart
However RSI value is going up at the same time
This is an indication of downtrend exhaustion
Stop Loss to be put below previous pivot low
0.12USD
158.03 KUSD
12.25 MUSD
1.03 M
About Guardion Health Sciences, Inc.
Sector
CEO
Jan Hall
Headquarters
Houston
Website
Employees (FY)
9
Founded
2009
FIGI
BBG00FF4HHX9
Guardion Health Sciences, Inc. engages in the development and distribution of clinically supported dietary supplements and medical foods. The firm also offers science-based products and devices designed to support healthcare professionals, providers, patients, and consumers. The company was founded by Michael Favish in December 2009 and is headquartered in Houston, TX.
GHSI LongAn upside breakout from a Continuation Wedge was confirmed. After a temporary interruption, the prior uptrend is set to continue. The pattern formed over 13 hours and 15 minutes, which is a rough guide for how long it might take to reach the target price of 0.29 - 0.31.
Guardion Health (NASDAQ: $GHSI) Could Go Boom In 2022 💥Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macu
GHSI Chart AnalysisUpon review Bullish divergence can be seen following an uptrend.
12ema is crossing over 26sma indicating trend change.
26 sma is also approaching 200 sma is indicate trend change.
Buying pressure is increasing
The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlo
Multiple Flag and Pennants, Might See A Nice One Here Today!GHSI on multiple flags and pennants. Might see a repeating pattern. Next PT $1.50 until we see more.
GHSI: Ascending triangle, confirmedAscending Triangle, confirmed.
Pros:
Descending volume during formation
Volume increase at break out
Golden cross in blue
PPS above 50MA and 200MA
RS above 0, and ascending
ATR Ascending
R/R ratio above 5
Cons:
200MA flat
250RSI below 50
PT = 1.59$
Trade Alert Pt.2: GHSI We are back in action here @ GHSI.
My first alert took a bit longer than I thought it would but finally back at price of July/Aug 2019.
Big body of Cup formed and migght see a small pullback (handle) and then launch into green zone. I have no Idea how high this might go but PT1 : $1.6
should then c
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GHSI is 8.28 USD — it has increased by 3.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Guardion Health Sciences, Inc. stocks are traded under the ticker GHSI.
Guardion Health Sciences, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
GHSI stock is 3.40% volatile and has beta coefficient of 0.74. Check out the list of the most volatile stocks — is Guardion Health Sciences, Inc. there?
GHSI earnings for the last quarter are 0.29 USD per share, whereas the estimation was −0.81 USD resulting in a 135.80% surprise. The estimated earnings for the next quarter are −0.73 USD per share. See more details about Guardion Health Sciences, Inc. earnings.
Guardion Health Sciences, Inc. revenue for the last quarter amounts to 3.34 M USD despite the estimated figure of 3.08 M USD. In the next quarter revenue is expected to reach 2.96 M USD.
Yes, you can track Guardion Health Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
GHSI stock has risen by 5.21% compared to the previous week, the month change is a 8.20% fall, over the last year Guardion Health Sciences, Inc. has showed a 30.39% increase.
GHSI net income for the last quarter is 424.72 K USD, while the quarter before that showed 372.63 K USD of net income which accounts for 13.98% change. Track more Guardion Health Sciences, Inc. financial stats to get the full picture.
Today Guardion Health Sciences, Inc. has the market capitalization of 10.63 M, it has decreased by 9.91% over the last week.
No, GHSI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GHSI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Guardion Health Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 9.00 employees. See our rating of the largest employees — is Guardion Health Sciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Guardion Health Sciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Guardion Health Sciences, Inc. stock shows the sell signal. See more of Guardion Health Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Guardion Health Sciences, Inc. future price: according to them, GHSI price has a max estimate of 12.00 USD and a min estimate of 12.00 USD. Read a more detailed Guardion Health Sciences, Inc. forecast: see what analysts think of Guardion Health Sciences, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Guardion Health Sciences, Inc. EBITDA is −3.92 M USD, and current EBITDA margin is −32.02%. See more stats in Guardion Health Sciences, Inc. financial statements.